Tampa Company Expands Clinical Trials of Cancer Vaccine
UF startup and UF Innovate | Sid Martin Biotech alum Morphogenesis, Inc., a clinical-stage immunotherapy company headquartered in Tampa, is moving forward with clinical trials of a cancer vaccine after getting FDA approval. The company developed the vaccine after decades of research and study. Earlier trials showed promise in larger animals afflicted with melanoma. Now […]
Experts Identify the Technology Driving Industry Advancement in 2020
As 2019 neared its end and experts around the world raced to predict which technology trends would shape the new decade, artificial intelligence (AI) and its role in accelerating automation was a common theme. Indeed, in its outlook on top technology trends for 2020, global research and advisory company Gartner listed hyperautomation as No. 1. […]
AGTC Announces Agenda for R&D Day on January 28, 2020 in New York
UF startup and UF Innovate | Sid Martin Biotech alum Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, announced that it will host an R&D Day beginning at 7:30 am ET on Tuesday, January 28, 2020, in New York. […]
RTI Surgical Holdings, Inc.® Announces Sale of OEM Business and Preliminary Fourth Quarter and Full Year 2019 Revenues
UF Innovate | Sid Martin Biotech alum RTI Surgical Holdings, Inc., a global surgical implant company, announced a definitive agreement for the sale of the company’s OEM business to Montagu Private Equity LLP, a leading European private equity firm, for a total consideration of $490 million. The transaction is targeted to close in the first […]
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2019 and Provides 2020 Annual Guidance
UF startup and UF Innovate | Sid Martin Biotech alum Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announced preliminary unaudited fourth quarter and full-year 2019 revenue. “We delivered solid revenue growth in both the fourth quarter and the full year, and I am pleased with the […]
AGTC Reports Positive Six-Month Data From Its Ongoing Phase 1/2 Clinical Trial in X-Linked Retinitis Pigmentosa
UF startup and UF Innovate | Sid Martin Biotech alum Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, reported positive interim six-month data from its ongoing Phase 1/2 clinical program in X-linked retinitis pigmentosa (XLRP). The results show that […]
Avance® Nerve Graft Recipient Selected to Ride on Donate Life Rose Parade® Float
UF startup and UF Innovate | Sid Martin Biotech graduate company Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, selected Jessica de Paz to ride on the 2020 Donate Life Rose Parade float that was featured in the annual Tournament of Roses® parade. The […]
Axogen Awarded Research Grant From the Advanced Regenerative Manufacturing Institute
UF startup and UF Innovate | Sid Martin Biotech alum Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, announced it has been awarded a grant to research and develop an automated bioprocessing system for human tissue scaffolds. Axogen’s partnership with the Advanced Regenerative Manufacturing […]
RTI Surgical® Announces Cigna’s Positive Medical Coverage Policy for Minimally Invasive SI Joint Fusion Surgery
UF Innovate | Sid Martin Biotech alum RTI Surgical, Inc., a global surgical implant company, announced that Cigna Corporation, a global health service company, issued a positive medical coverage policy for minimally invasive sacroiliac (SI) joint fusion under certain medically necessary criteria. This policy covers the use of all FDA-cleared implants placed across the SI […]
Oragenics Working on Treatment for Oral Mucositis With Promising AG013 Product
Alan Joslyn, CEO of UF startup and UF Innovate | Sid Martin Biotech alum Oragenics, Inc., a Tampa-based company leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis (OM), talked with Proactive’s Steve Darling at the 12th annual LD Micro Conference. The company is developing the AG013, which […]